article thumbnail

IEEE-ISTO Announces Formation of the Inter Company Quality Analytics (IMPALA) Consortium

ISTO / IEEE

IEEE-ISTO looks forward to supporting the important work of the Consortium’s mission to transform the biopharmaceutical QA process.” IEEE-ISTO provides today’s industry alliances and trade associations with turnkey legal and operational support. About IEEE-ISTO.

article thumbnail

Leadership in Biopharma: Key thought leaders in the Biopharma industry

Jake Jorgovan

With a rich background in biopharmaceuticals and a clear vision for integrating technology into marketing strategies, Figueiredo White is reshaping how biopharma companies interact with their audiences. Her platform, ZIPPYAR, is at the forefront of offering interactive packaging solutions, enhancing consumer engagement and product experience.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top 18 Medical Device Consultants & Consulting Firms

Jake Jorgovan

The Windshire Group: Is a comprehensive life science and management consulting firm founded in 2011 focusing on the pharmaceutical and biopharmaceutical industries. Their global presence and diverse range of services ensure a holistic and effective strategy for any project in the pharmaceutical and biopharmaceutical sectors.

article thumbnail

Top 12 BioPharma / Pharmaceutical Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

Industries: Pharmaceutical, Biotechnology, Medical Devices, Chemical, Agrochemical, Environmental, Agricultural, Engineering, Life Sciences, Clinical, Personal Care, FMCG, Forensic, Food & Beverage, Energy, Biopharmaceuticals, Diagnostics, Veterinary, Medical Technology, Tobacco, Laboratory Services, Aesthetics, Geology & Earth Sciences, Chemistry (..)

Biopharma 130
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Growth Opportunity 2 – Medical Cannabidiol (CBD) Global regulatory shifts toward legalizing medical cannabis and CBD products highlight the growing interest in cannabis-based treatments. Partnerships with specialty CDMOs experienced in manufacturing schedule 1 products can accelerate clinical trials and R&D.